Synthesis and Antiarrhythmic and Hemostatic Activity of [3,3-Dialkyl-3, 4-Dihydroisoquinolin-1(2H )-Ylidene]-N-Alkylacetamides
- Authors: Gashkova O.V.1, Mikhailovskii A.G.1, Rudakova I.P.1, Starkova A.V.1, Yusov A.S.1
- 
							Affiliations: 
							- Perm State Pharmaceutical Academy
 
- Issue: Vol 53, No 6 (2019)
- Pages: 507-510
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245833
- DOI: https://doi.org/10.1007/s11094-019-02028-6
- ID: 245833
Cite item
Abstract
[3,3-Dialkyl-3,4-dihydroisoqinolin-1(2H)-ylidene]-N-alkylacetamides were synthesized by reacting dialkylbenzylcarbinols with N-alkylcyanoacetamides. Hydrochlorides of the synthesized compounds existed in the imine form. All hydrochlorides showed antiarrhythmic and coagulant (hemostatic) effects. An amide with an unsubstituted amide N atom and a 3-spiro-cyclopentyl moiety was the most active compound with antiarrhythmic activity 2.8 times that of lidocaine and blood coagulation accelerated by 37.9%, which was 21.9% faster than etamsylate.
About the authors
O. V. Gashkova
Perm State Pharmaceutical Academy
														Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm, 614990						
A. G. Mikhailovskii
Perm State Pharmaceutical Academy
							Author for correspondence.
							Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm, 614990						
I. P. Rudakova
Perm State Pharmaceutical Academy
														Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm, 614990						
A. V. Starkova
Perm State Pharmaceutical Academy
														Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm, 614990						
A. S. Yusov
Perm State Pharmaceutical Academy
														Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm, 614990						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					